Clinical Trial Update: Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating zinc and nicotinamide riboside for idiopathic pulmonary fibrosis is currently recruiting. The sponsor is Cedars-Sinai Med…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)
• ZINC (Zinc chloride)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: RECRUITING